Read more at: Ultra-scale down bioreactors
Ultra-scale down bioreactors
Summary The majority of therapeutic antibodies are manufactured by mammalian cell culture processes exploiting Chinese hamster ovary (CHO) cells. Annual demands for such antibody products is likely to increase and is driving efforts to improve production capacity. Miniaturised platform cell culture...
